Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Phase 1 Study of Rezatapopt, a p53 Reactivator, in
TP53
Y220C–Mutated Tumors
Links
DOI
PubMed
Journal
New England Journal of Medicine
Funding
This study was sponsored by PMV Pharmaceuticals, Inc. Funding